Latest News about NVO
Recent news which mentions NVO
UK Becomes First Major Market for Eli Lilly's Mounjaro Prefilled Pen For Tackling Obesity
February 15, 2024
From Benzinga
What's Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk's Weight Loss Drug Wegovy
February 15, 2024
From Benzinga
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
From InvestorPlace
Tickers
NVO
From Motley Fool
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
February 14, 2024
From Motley Fool
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
February 13, 2024
From InvestorPlace
Altimmune Stock Sinks As Kerrisdale Capital Announces Short Position: 'Obvious Dead End'
February 13, 2024
From Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
February 13, 2024
From Benzinga
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
February 13, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
From Benzinga
Novo Nordisk's Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement
February 12, 2024
From Benzinga
2 Value Stocks With Monster Yields
February 12, 2024
From Motley Fool
Novo Nordisk's Magic Run Continues Even With Increasing Competition
February 12, 2024
Tickers
NVO
From Motley Fool
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs
February 12, 2024
From Benzinga
Wall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names
February 12, 2024
From Motley Fool
Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?
February 12, 2024
From Motley Fool
Ozempic Maker's Parent Company To Invest $7B Annually By 2030: 'We Have More Money Than Ever To Invest'
February 12, 2024
From Benzinga
From Motley Fool
Don't Worry About Novo Nordisk's Premium Stock Price. It's Still a Buy.
February 11, 2024
Tickers
NVO
From Motley Fool
From Motley Fool
3 Stocks That Could Trounce the Market in 2024
February 10, 2024
From Motley Fool
S&P 500 Hits 5,000, Magnificent 7 Tops $13 Trillion, Commercial Real Estate Cracks Emerge: The Week In The Markets
February 09, 2024
From Benzinga
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
February 08, 2024
From Motley Fool
What's Going On Eli Lilly Stock Thursday?
February 08, 2024
From Benzinga
Prediction: 2 Stocks That Could Trounce the Market
February 08, 2024
From Motley Fool
The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry
February 08, 2024
From Benzinga
How Important Are Ozempic and Wegovy to Novo Nordisk's Business?
February 08, 2024
Tickers
NVO
From Motley Fool
Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns
February 07, 2024
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.